1. Agudo, A., Peluso, M., Munnia, A., Luján-Barroso, L., Sánchez, M. J., Molina-Montes, E., et al. (2012). Aromatic DNA adducts and risk of gastrointestinal cancers: A case-cohort study within the EPIC-Spain. Cancer Epidemiological Biomarkers and Prevention, 21(4), 685–692.
2. Anthony, J. C. (1988). The epidemiologic case–control strategy, with applications in psychiatric research. In A. S. Henderson & G. D. Burrows (Eds.), Handbook of social psychiatry (pp. 157–171). Amsterdam: Elsevier Science Publishers.
3. Anthony, J. C. (1990). Prevention research in the context of epidemiology, with a discussion of public health models. In P. Muehrer (Ed.), Conceptual research models for preventing mental disorders (pp. 1–32) (DHHS Publication No. ADM 90-1713). Washington, DC: GPO.
4. Anthony, J. C., Breitner, J. C., Zandi, P. P., Meyer, M. R., Jurasova, I., Norton, M. C., et al. (2000). Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: The Cache County study. Neurology, 54(11), 2066–2071.
5. Dodge, K. A., Malone, P. S., Lansford, J. E., Miller, S., Pettit, G. S., & Bates, J. E. (2009). A dynamic cascade model of the development of substance use onset. Monographs of the Society for Research on Child Development, 74(3), vii–119.